A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence

被引:0
|
作者
Nadine H. Brückmann
Sofie N. Bennedsen
Pascal H. G. Duijf
Mikkel G. Terp
Mads Thomassen
Martin Larsen
Christina B. Pedersen
Torben Kruse
Nicolas Alcaraz
Henrik J. Ditzel
Morten F. Gjerstorff
机构
[1] University of Southern Denmark,Department of Cancer and Inflammation Research, Institute for Molecular Medicine
[2] Queensland University of Technology,Institute of Health and Biomedical Innovation, Faculty of Health, School of Biomedical Sciences
[3] The University of Queensland,University of Queensland Diamantina Institute
[4] Translational Research Institute,Department of Clinical Genetics
[5] Odense University Hospital,Department of Oncology
[6] Odense University Hospital,Academy of Geriatric Cancer Research (AgeCare)
[7] Odense University Hospital,undefined
来源
Cell Death & Disease | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The senescence response to oncogenes is believed to be a barrier to oncogenic transformation in premalignant lesions, and describing the mechanisms by which tumor cells evade this response is important for early diagnosis and treatment. The male germ cell-associated protein SSX2 is ectopically expressed in many types of cancer and is functionally involved in regulating chromatin structure and supporting cell proliferation. Similar to many well-characterized oncogenes, SSX2 has the ability to induce senescence in cells. In this study, we performed a functional genetic screen to identify proteins implicated in SSX2-induced senescence and identified several subunits of the Mediator complex, which is central in regulating RNA polymerase-mediated transcription. Further experiments showed that reduced levels of MED1, MED4, and MED14 perturbed the development of senescence in SSX2-expressing cells. In contrast, knockdown of MED1 did not prevent development of B-Raf- and Epirubicin-induced senescence, suggesting that Mediator may be specifically linked to the cellular functions of SSX2 that may lead to development of senescence or be central in a SSX2-specific senescence response. Indeed, immunostaining of melanoma tumors, which often express SSX proteins, exhibited altered levels of MED1 compared to benign nevi. Similarly, RNA-seq analysis suggested that MED1, MED4, and MED14 were downregulated in some tumors, while upregulated in others. In conclusion, our study reveals the Mediator complex as essential for SSX2-induced senescence and suggests that changes in Mediator activity could be instrumental for tumorigenesis.
引用
收藏
相关论文
共 50 条
  • [21] A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion
    Egan, Elizabeth S.
    Jiang, Rays H. Y.
    Moechtar, Mischka A.
    Barteneva, Natasha S.
    Weekes, Michael P.
    Nobre, Luis V.
    Gygi, Steven P.
    Paulo, Joao A.
    Frantzreb, Charles
    Tani, Yoshihiko
    Takahashi, Junko
    Watanabe, Seishi
    Goldberg, Jonathan
    Paul, Aditya S.
    Brugnara, Carlo
    Root, David E.
    Wiegand, Roger C.
    Doench, John G.
    Duraisingh, Manoj T.
    SCIENCE, 2015, 348 (6235) : 711 - 714
  • [22] Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence
    Han, Ruiqi
    Li, Li
    Ugalde, Alejandro Pineiro
    Tal, Arieh
    Manber, Zohar
    Barbera, Eric Pinto
    Della Chiara, Veronica
    Elkon, Ran
    Agami, Reuven
    GENOME BIOLOGY, 2018, 19
  • [23] Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence
    Ruiqi Han
    Li Li
    Alejandro Piñeiro Ugalde
    Arieh Tal
    Zohar Manber
    Eric Pinto Barbera
    Veronica Della Chiara
    Ran Elkon
    Reuven Agami
    Genome Biology, 19
  • [24] An in vivo shRNA functional genomics screen identifies transcriptional and epigenetic regulators that are essential in lung tumorigenesis
    Hight, Suzie K.
    McMillan, Elizabeth
    Shao, Chunli
    Girard, Luc
    Canales, Jaime Rodriguez
    White, Michael A.
    Wistuba, Ignacio I.
    Mangelsdorf, David
    Minna, John D.
    CANCER RESEARCH, 2015, 75 (22)
  • [25] A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
    Pettitt, Stephen J.
    Rehman, Farah L.
    Bajrami, Ilirjana
    Brough, Rachel
    Wallberg, Fredrik
    Kozarewa, Iwanka
    Fenwick, Kerry
    Assiotis, Ioannis
    Chen, Lina
    Campbell, James
    Lord, Christopher J.
    Ashworth, Alan
    PLOS ONE, 2013, 8 (04):
  • [26] A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors
    Epping, Mirjam T.
    Wang, Liming
    Plumb, Jane A.
    Lieb, Michele
    Gronemeyer, Hinrich
    Brown, Robert
    Bernards, Rene
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (45) : 17777 - 17782
  • [27] A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis
    Taha Azad
    Kazem Nouri
    Helena J. Janse van Rensburg
    Sarah M. Maritan
    Liqing Wu
    Yawei Hao
    Tess Montminy
    Jihang Yu
    Prem Khanal
    Lois M. Mulligan
    Xiaolong Yang
    Oncogene, 2020, 39 : 334 - 355
  • [28] A genetic screen to Drosophila identifies new interactors of the chromosomal passenger complex with roles in cytokinesis
    Carmena, M
    Goulding, SE
    Chang, C
    Earnshaw, WC
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 444A - 444A
  • [29] A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis
    Azad, Taha
    Nouri, Kazem
    van Rensburg, Helena J. Janse
    Maritan, Sarah M.
    Wu, Liqing
    Hao, Yawei
    Montminy, Tess
    Yu, Jihang
    Khanal, Prem
    Mulligan, Lois M.
    Yang, Xiaolong
    ONCOGENE, 2020, 39 (02) : 334 - 355
  • [30] A genetic method identifies thioredoxin reductase as a mediator of interferon and retinoid induced cell death
    Hofmann, ER
    Boyanapalli, MM
    Lindner, DJ
    Xiao, WH
    Kalvakolanu, DV
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 375 - 375